{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:36:05Z","timestamp":1791974165693,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1245\/s10434-021-10860-y","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T23:36:38Z","timestamp":1633476998000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer"],"prefix":"10.1245","volume":"29","author":[{"given":"R\u00e9my","family":"Sindayigaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric Remy","family":"Demtr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Robin","family":"Buggisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens B.","family":"Tempfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ouaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Giger-Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"10860_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomatran I, Siegel RL, Torre LA, Semal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"10860_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4251\/wjgo.v12.i5.569","volume":"12","author":"R Yarema","year":"2020","unstructured":"Yarema R, Ohorchak M, Hyrya P, Kovalchuk Y, Safiyan V, Karelin I, et al. Gastric cancer with peritoneal metastases: efficiency of standard treatment methods. WJGO. 2020;12:569\u201381.","journal-title":"WJGO"},{"key":"10860_CR3","doi-asserted-by":"crossref","unstructured":"Peritoneum Registry of the German Society for General and Visceral Surgery (DGAV), for the Peritoneum Surface Oncology Group and members of the StuDoQ, Rau B, Brandl A, Piso P, Pelz J, Busch P, et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2020;23:11\u201322.","DOI":"10.1007\/s10120-019-00978-0"},{"key":"10860_CR4","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"S-E Al-Batran","year":"2019","unstructured":"Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393:1948\u201357.","journal-title":"Lancet"},{"key":"10860_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"S-E Al-Batran","year":"2017","unstructured":"Al-Batran S-E, Homann N, Pauligk C, Illerhaus G, Martens UM, Stoehlmacher J, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3:1237.","journal-title":"JAMA Oncol."},{"key":"10860_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4613-1247-5_4","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Cancer Treat Res. 1996;82:53\u201363.","journal-title":"Cancer Treat Res."},{"key":"10860_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.cr.7310118","volume":"17","author":"F Li","year":"2007","unstructured":"Li F, Tiede B, Massagu J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007;17:3\u201314.","journal-title":"Cell Res"},{"issue":"2","key":"10860_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/CRR.1000148","volume":"2","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Yonemura Y, Ishibashi H, Mizumoto A, Wakama S, Cocolini F. Recent advances in the treatment of peritoneal metastasis from gastric cancer. Cancer Rep Rev. 2018;2(2):1\u20136. https:\/\/doi.org\/10.15761\/CRR.1000148.","journal-title":"Cancer Rep Rev."},{"issue":"12","key":"10860_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2174\/1389201019666181114121145","volume":"19","author":"S Zhang","year":"2018","unstructured":"Zhang S, Feng R, Pan Z, Lin M, Jiang T, Huang X, et al. Clinical efficacy of combination intravenous and intraperitoneal chemotherapy in the treatment of gastric cancer with peritoneal carcinomatosis. Curr Pharm Biotechnol. 2018;19(12):956\u201362. https:\/\/doi.org\/10.2174\/1389201019666181114121145.","journal-title":"Curr Pharm Biotechnol."},{"key":"10860_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575\u201381.","journal-title":"Ann Surg Oncol."},{"key":"10860_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1245\/s10434-013-3208-y","volume":"21","author":"J Kitayama","year":"2014","unstructured":"Kitayama J, Ishigami H, Yamaguchi H, Yamashita H, Emoto S, Kaisaki S, et al. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. Ann Surg Oncol. 2014;21:539\u201346. https:\/\/doi.org\/10.1245\/s10434-013-3208-y.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 1","key":"10860_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10120-016-0660-y","volume":"20","author":"K Kono","year":"2017","unstructured":"Kono K, Yong WP, Okayama H, Shabbir A, Momma T, Ohki S, et al. Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan. Gastric Cancer. 2017;20(Suppl 1):122\u20137. https:\/\/doi.org\/10.1007\/s10120-016-0660-y.","journal-title":"Gastric Cancer"},{"key":"10860_CR13","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","volume":"24","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Blum M, Das P, Estrella J, Wang K, Ho L, et al. Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma. Ann Surg Oncol. 2017;24:3338\u201344.","journal-title":"Ann Surg Oncol."},{"key":"10860_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J Clin Oncol. 2018;36:19.","journal-title":"J Clin Oncol."},{"key":"10860_CR15","doi-asserted-by":"publisher","unstructured":"Chicago Consensus Working Group, Izquierdo FJ, Schuitevoerder D,\u00a0et al.\u00a0The Chicago Consensus on Peritoneal Surface Malignancies: management of gastric metastases.\u00a0Ann Surg Oncol.\u00a02020;27:1768\u201373. https:\/\/doi.org\/10.1245\/s10434-020-08320-0.","DOI":"10.1245\/s10434-020-08320-0"},{"key":"10860_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","volume":"12","author":"G Nadiradze","year":"2020","unstructured":"Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich FJ, K\u00f6nigsrainer A, et al. Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2020;12:34. https:\/\/doi.org\/10.3390\/cancers12010034.","journal-title":"Cancers."},{"key":"10860_CR17","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-019-07695-z","volume":"26","author":"U Giger-Pabst","year":"2019","unstructured":"Giger-Pabst U, Bucur P, Roger S, Falkenstein TA, Tabchouri N, Le Pape A, et al. Comparison of tissue and blood concentrations of oxaliplatin administrated by different modalities of intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26:4445\u201351. https:\/\/doi.org\/10.1245\/s10434-019-07695-z.","journal-title":"Ann Surg Oncol."},{"key":"10860_CR18","doi-asserted-by":"publisher","first-page":"29024","DOI":"10.1021\/acsami.0c05554","volume":"12","author":"M Shariati","year":"2020","unstructured":"Shariati M, Lollo G, Matha K, Descamps B, Vanhove C, van de Sande L, et al. Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer. ACS Appl Mater Interfaces. 2020;12:29024\u201336. https:\/\/doi.org\/10.1021\/acsami.0c05554.","journal-title":"ACS Appl Mater Interfaces."},{"key":"10860_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond M-A. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg. 2016;20:367\u201373.","journal-title":"J Gastrointest Surg."},{"key":"10860_CR20","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","volume":"22","author":"U Giger-Pabst","year":"2018","unstructured":"Giger-Pabst U, Tempfer CB. How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures. J Gastrointest Surg. 2018;22:2187\u201393.","journal-title":"J Gastrointest Surg."},{"key":"10860_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s003840050072","volume":"12","author":"O Dworak","year":"1997","unstructured":"Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19\u201323.","journal-title":"Int J Colorectal Dis."},{"key":"10860_CR22","unstructured":"International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (PIPACRegis). ClinicalTrials.gov Identifier: NCT03210298. Retrieved at 15 May 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03210298."},{"key":"10860_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the peritoneal regression grading score (PRGS). Pleura Peritoneum. 2016;1:99\u2013107.","journal-title":"Pleura Peritoneum."},{"key":"10860_CR24","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. Published 28 May 2009 (v4.03: 14 June 2010). U.S. Department of Health and Human Services. National Institutes of Health, National Cancer Institute."},{"key":"10860_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, Laplace N, Villeneuve L, Passot G, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47:123\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.021.","journal-title":"Eur J Surg Oncol."},{"key":"10860_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.suronc.2020.05.006","volume":"34","author":"A Di Giorgio","year":"2020","unstructured":"Di Giorgio A, Schena CA, El Halabieh MA, Abatini C, Vita E, Strippoli A, et al. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a bidirectional approach for gastric cancer peritoneal metastasis. Surg Oncol. 2020;34:270\u20135. https:\/\/doi.org\/10.1016\/j.suronc.2020.05.006.","journal-title":"Surg Oncol."},{"key":"10860_CR27","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","volume":"43","author":"M Alyami","year":"2017","unstructured":"Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, et al. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43:2178\u201383.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"10860_CR28","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","volume":"28","author":"N Tabchouri","year":"2021","unstructured":"Tabchouri N, Buggisch J, Demtr\u00f6der CR, Thiery J, Rezniczek G, Tempfer CB, et al. Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases. Ann Surg Oncol. 2021;28(9):5275\u201386. https:\/\/doi.org\/10.1245\/s10434-020-09508-0.","journal-title":"Ann Surg Oncol."},{"key":"10860_CR29","doi-asserted-by":"publisher","first-page":"175883591984640","DOI":"10.1177\/1758835919846402","volume":"11","author":"F Struller","year":"2019","unstructured":"Struller F, Horvath P, Solass W, Weinreich FJ, Strumberg D, Kokkalis MK, et al. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Ther Adv Med Oncol. 2019;11:1758835919846402. https:\/\/doi.org\/10.1177\/1758835919846402.","journal-title":"Ther Adv Med Oncol."},{"issue":"1","key":"10860_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12885-020-6572-6","volume":"20","author":"M Ploug","year":"2020","unstructured":"Ploug M, Graversen M, Pfeiffer P, Mortensen MB. Bidirectional treatment of peritoneal metastasis with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and systemic chemotherapy: a systematic review. BMC Cancer. 2020;20(1):105. https:\/\/doi.org\/10.1186\/s12885-020-6572-6.","journal-title":"BMC Cancer."},{"issue":"15 Suppl","key":"10860_CR31","doi-asserted-by":"publisher","first-page":"e16538","DOI":"10.1200\/JCO.2020.38.15_suppl.e16538","volume":"38","author":"PE Bonnot","year":"2020","unstructured":"Bonnot PE, Rabel T, Lintis A, Laplace N, Bakrin N, Kepenekian V, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated to systemic chemotherapy for gastric cancer with diffuse peritoneal metastases in a palliative setting. J Clin Oncol. 2020;38(15 Suppl):e16538\u2013e16538.","journal-title":"J Clin Oncol."},{"key":"10860_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","volume":"18","author":"I Gockel","year":"2018","unstructured":"Gockel I, Jansen-Winkeln B, Haase L, Rhode P, Mehdorn M, Niebisch S, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study. J Gastric Cancer. 2018;18:379\u201391. https:\/\/doi.org\/10.5230\/jgc.2018.18.e37.","journal-title":"J Gastric Cancer."},{"key":"10860_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000290955","volume":"78","author":"J Kitayama","year":"2010","unstructured":"Kitayama J, Ishigami H, Kaisaki S, Hidemura A, Kato M, Otani K, et al. Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer. Oncology. 2010;78:40\u20136. https:\/\/doi.org\/10.1159\/000290955.","journal-title":"Oncology."},{"key":"10860_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10147-010-0135-9","volume":"16","author":"TE Nakajima","year":"2011","unstructured":"Nakajima TE, Nakamura K, Takashima A, Kato K, Hamaguchi T, Yamada Y, et al. Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study. Int J Clin Oncol. 2011;16:57\u201362. https:\/\/doi.org\/10.1007\/s10147-010-0135-9.","journal-title":"Int J Clin Oncol."},{"key":"10860_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10120-011-0016-6","volume":"14","author":"H Imamoto","year":"2011","unstructured":"Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, et al. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced\/recurrent gastric cancer. Gastric Cancer. 2011;14:81\u201390. https:\/\/doi.org\/10.1007\/s10120-011-0016-6.","journal-title":"Gastric Cancer."},{"key":"10860_CR36","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.12998\/wjcc.v7.i20.3247","volume":"7","author":"LN Zheng","year":"2019","unstructured":"Zheng LN, Wen F, Xu P, Zhang S. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: a systemic review and meta-analysis. World J Clin Cases. 2019;7:3247\u201358. https:\/\/doi.org\/10.12998\/wjcc.v7.i20.3247.","journal-title":"World J Clin Cases."},{"key":"10860_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1749-7922-8-6","volume":"8","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Ansaloni L, Manfredi R, Campanati L, Poiasina E, Bertoli P, et al. Peritoneal adhesion index (PAI): proposal of a score for the \u201cignored iceberg\u201d of medicine and surgery. World J Emerg Surg. 2013;8:6.","journal-title":"World J Emerg Surg."},{"key":"10860_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/his.14092","volume":"77","author":"N Benzerdjeb","year":"2020","unstructured":"Benzerdjeb N, Durieux E, Tantot J, Isaac S, Fontaine J, Harou O, et al. Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis. Histopathology. 2020;77:548\u201359. https:\/\/doi.org\/10.1111\/his.14092.","journal-title":"Histopathology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10860-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T13:19:40Z","timestamp":1639660780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10860-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10860"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10860-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thierry Lecomte has received payments for clinical research\/scientific work from Sanofi Genzyme and Merck; he is a consultant and expert for Sanofi Genzyme; he has conducted courses and training for Merck, Amgen and Lilly. He has received invitations to national and international congresses from Amgen and Servier. All other authors have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}